United States - English - NLM (National Library of Medicine)

trilipid research institute, llc - homosalate 10%, ethylhexyl methoxycinnamate 7.5%, butyl methoxydibenzoylmethane 3%, octocrylene 2.7% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun. on damaged or broken skin. if rash occurs.

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - octocrylene, quantity: 20 mg/g; homosalate, quantity: 80 mg/g; butyl methoxydibenzoylmethane, quantity: 25 mg/g - spray - excipient ingredients: light liquid paraffin; isopropyl myristate; coconut oil; propyl hydroxybenzoate; butylated hydroxytoluene; almond oil; colloidal anhydrous silica; fragrance (perfume) - spf 15 broad spectrum medium/moderate protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - octocrylene, quantity: 10 mg/g; phenylbenzimidazole sulfonic acid, quantity: 10 mg/g; octyl salicylate, quantity: 40 mg/g; butyl methoxydibenzoylmethane, quantity: 20 mg/g - lotion - excipient ingredients: methyl hydroxybenzoate; c13-14 isoparaffin; cetyl alcohol; polyethylene; isopropyl palmitate; panthenol; cetostearyl alcohol; nicotinamide; aloe vera; propyl hydroxybenzoate; ethyl hydroxybenzoate; laureth-7; aluminium starch octenylsuccinate; benzyl alcohol; disodium edetate; peg-100 stearate; trolamine; dimeticone 200; glycerol; d-alpha-tocopheryl acetate; propylene glycol; purified water; dimeticonol; matricaria chamomilla; cetearyl glucoside; stearyl alcohol; sorbitan stearate; stearic acid; polyacrylamide - spf 15 broad spectrum medium/moderate protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen)

United States - English - NLM (National Library of Medicine)

zhejiang ayan biotech co.,ltd. - octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - octocrylene 80 mg in 1 g - - helps prevent sunburn.

United States - English - NLM (National Library of Medicine)

avpak - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome ( see warnings and dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period after myocardial infarction.

United States - English - NLM (National Library of Medicine)

zhejiang ayan biotech co.,ltd. - octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y), avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox) - - helps prevent sunburn.

United States - English - NLM (National Library of Medicine)

concordia pharmaceuticals inc. - phenoxybenzamine hydrochloride (unii: x1ieg24ohl) (phenoxybenzamine - unii:0ttz664r7z) - phenoxybenzamine hydrochloride 10 mg - conditions where a fall in blood pressure may be undesirable; hypersensitivity to the drug or any of its components.

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - adapalene 3 mg in 1 g - epiduo forte is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. epiduo forte is contraindicated in patients with a history of hypersensitivity reactions to benzoyl peroxide or any components of the formulation in epiduo forte. risk summary available pharmacovigilance data with epiduo forte use in pregnant women are insufficient to establish a drug associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. animal reproduction studies have not been conducted with the combination gel. adapalene gel, 0.3% available data from clinical trials with adapalene gel 0.3% use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. in animal reproduction studies, oral administration of adapalene to pregnant rats and rabbits during organogenesis at dose exposures 41 and 81 times, respectively, the human exposure at the ma

Australia - English - Department of Health (Therapeutic Goods Administration)

unilever australia limited - butyl methoxydibenzoylmethane,octyl salicylate,phenylbenzimidazole sulfonic acid -

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - dronabinol (unii: 7j8897w37s) (dronabinol - unii:7j8897w37s) - dronabinol 2.5 mg - dronabinol capsules are indicated for the treatment of: - anorexia associated with weight loss in patients with aids; and - nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. dronabinol capsules are contraindicated in any patient who has a known sensitivity to dronabinol or any of its ingredients. it contains cannabinoid and sesame oil and should never be used by patients allergic to these substances. dronabinol is one of the psychoactive compounds present in cannabis, and is abusable and controlled [schedule iii (ciii)] under the controlled substances act. both psychological and physiological dependence have been noted in healthy individuals receiving dronabinol, but addiction is uncommon and has only been seen after prolonged high dose administration. chronic abuse of cannabis has been associated with decrements in motivation, cognition, judgment, and perception. the etiology of these impairments is unknown, but ma